Frost & Sullivan Independent Equity Research

RedHill Biopharma Ltd.: The Strategic Expansion and Clinical Progress are in line with the Company’s plans. Stock Target Price Unchanged.

Company: RedHill Biopharma Ltd.        

Sector: Pharmaceuticals

Report type: Quarterly Report

Published on: August 8th, 2017

RedHill research articles:

Close Menu
Font Resize